Comparison of clinical efficacy between peramivir and oseltamivir for the treatment of influenza in high-risk patients
Not Applicable
- Conditions
- Influenza virus infection
- Registration Number
- JPRN-UMIN000010595
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
(i) Chronic respiratory failure requiring artificial ventilation (ii) Diabetes with an HbA1c value of >=10% (iii) Organ transplant or hematopoietic stem cell transplant within the previous 12 months (iv) Requirement for dialysis or presence of nephropathy (estimated creatinine clearance, <50 ml/min) (v) Presence of a complicating infection judged to require treatment by systemic administration of an antimicrobial agent (vi) Contraindication of peramivir and oseltamivir (vii) Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The duration of influenza illness
- Secondary Outcome Measures
Name Time Method The duration of fever, Complications